Biopsychosocial Factors Associated with Cigarette and E-cigarette Use in Smokers with Affective Disorders
与患有情感障碍的吸烟者使用香烟和电子烟相关的生物心理社会因素
基本信息
- 批准号:9982043
- 负责人:
- 金额:$ 4.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-01 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAnxiety DisordersAreaBeliefCessation of lifeCigaretteDependenceDiseaseEffectivenessElasticityElectronic cigaretteFellowshipGeneral PopulationHarm ReductionHealthIndividualInterviewKnowledgeMeasuresMental DepressionMental HealthMethodsMood DisordersMorbidity - disease rateNicotineNicotine DependenceParentsParticipantPriceRandomizedRandomized Clinical TrialsRandomized Controlled TrialsRegulationRelapseRelative RisksResearchResearch MethodologyResearch PersonnelSamplingSmokerSmokingSourceTimeTobaccoTobacco DependenceToxicant exposureToxinTrainingUnited States Food and Drug AdministrationVulnerable PopulationsWithdrawal Symptombasebehavioral economicsbiopsychosocialcigarette smokingcravingelectronic cigarette useexperiencemortalitynon-compliancenovelparent grantparent projectpre-doctoralpreferencepsychiatric symptomreduce tobacco useresponserisk perceptionsmoking cessationsmoking prevalencesocialsuccesstobacco productstobacco toxicant
项目摘要
ABSTRACT
Affective disorders (ADs, i.e., depression and anxiety disorders), are the most common mental health
conditions in the US. The prevalence of smoking among people with ADs is twice that of the general
population. Smokers with ADs make as many attempts to quit smoking as those without ADs, but are more
likely to relapse during quit attempts. As a result, people with ADs suffer from disproportionately-high rates of
tobacco-related disease and death. In July 2017, the Food and Drug Administration (FDA) announced a
comprehensive plan for regulating tobacco and nicotine products. A cornerstone of this plan is to reduce the
nicotine content of cigarettes to a minimally-addictive level, in order to reduce tobacco dependence in the US.
The parent project upon which this Predoctoral Fellowship to Promote Diversity in Health-Related Research
(F31 - Diversity) application will build is a randomized clinical trial that will examine whether very low nicotine
content cigarettes (VLNCCs) reduce smoking rates in smokers with ADs, and whether providing e-cigarettes
enhances this effect. Smokers with ADs will be randomized to one of the following conditions for 16 weeks: (1)
normal nicotine content research cigarettes (NNCCs) only, (2) VLNCCs only, (3) VLNCCs + tobacco-flavored
e-cigarettes, or (4) VLNCCs + preferred-flavor e-cigarettes. Based on previous research, we expect that
participants randomized to VLNCCs with or without e-cigarettes will partially but not fully substitute these study
products for their usual cigarettes. This F31 will add a single session at the end of the parent grant for
participants who had access to VLNCCs, e-cigarettes, and usual-brand cigarettes (i.e., those in conditions 3
and 4). The candidate will (1) investigate temporal and social-environmental contexts, relative risk perceptions,
and subjective experiences of VLNCC, e-cigarette and usual brand cigarette use among individuals with ADs,
(2) use a behavioral economics cross-price elasticity task to compare the relative reinforcing effects of
VLNCCs, e-cigarettes and usual-brand cigarettes among individuals with ADs, and (3) investigate participants’
opinions concerning a reduced-nicotine standard for cigarettes, whether and how they might circumvent such
regulation, and whether the availability of e-cigarettes would affect the likelihood of their complying with this
regulation. The proposed research will help us to understand factors contributing to VLNCC, e-cigarette and
usual brand cigarette use in smokers with ADs. In turn, this knowledge may help regulators to maximize the
effectiveness of a reduced-nicotine standard for cigarettes.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Teresa E DeAtley其他文献
Teresa E DeAtley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Teresa E DeAtley', 18)}}的其他基金
Biopsychosocial Factors Associated with Cigarette and E-cigarette Use in Smokers with Affective Disorders
与患有情感障碍的吸烟者使用香烟和电子烟相关的生物心理社会因素
- 批准号:
10197085 - 财政年份:2019
- 资助金额:
$ 4.55万 - 项目类别:
相似海外基金
Using generative AI combined with immersive technology to treat anxiety disorders
利用生成式人工智能结合沉浸式技术治疗焦虑症
- 批准号:
10109165 - 财政年份:2024
- 资助金额:
$ 4.55万 - 项目类别:
Launchpad
Integration of stepped care for Perinatal Mood and Anxiety Disorders among Women Living with HIV in Kenya
肯尼亚艾滋病毒感染妇女围产期情绪和焦虑障碍的分级护理一体化
- 批准号:
10677075 - 财政年份:2023
- 资助金额:
$ 4.55万 - 项目类别:
Understanding the Effects of Adolescent Nicotine Exposure on Increased Risk for Mood and Anxiety Disorders: Bridging the Gap from Pre-Clinical to Clinical Investigations
了解青少年尼古丁暴露对情绪和焦虑障碍风险增加的影响:弥合临床前研究与临床研究之间的差距
- 批准号:
478121 - 财政年份:2023
- 资助金额:
$ 4.55万 - 项目类别:
Operating Grants
Addressing perinatal mood and anxiety disorders (PMADs) through a doula intervention
通过导乐干预解决围产期情绪和焦虑障碍 (PMAD)
- 批准号:
10861961 - 财政年份:2023
- 资助金额:
$ 4.55万 - 项目类别:
Evaluation of the effectiveness and implementation of online group cognitive behavioral therapy for perinatal women with anxiety disorders.
评估在线团体认知行为治疗对患有焦虑症的围产期妇女的有效性和实施情况。
- 批准号:
22KJ3164 - 财政年份:2023
- 资助金额:
$ 4.55万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Investigating the error-related negativity and the balance N1 in children with anxiety disorders
调查焦虑症儿童的错误相关消极性和平衡 N1
- 批准号:
10685283 - 财政年份:2022
- 资助金额:
$ 4.55万 - 项目类别:
RESONY: Digital therapeutic to manage anxiety disorders
RESONY:管理焦虑症的数字疗法
- 批准号:
10042996 - 财政年份:2022
- 资助金额:
$ 4.55万 - 项目类别:
Grant for R&D
Augmenting the Efficacy of Benzodiazepine Taper with Telehealth-Delivered Cognitive Behavioral Therapy for Anxiety Disorders in Patients Using Prescription Opioids
通过远程医疗提供的认知行为疗法来增强苯二氮卓类药物逐渐减少的疗效,以治疗使用处方阿片类药物的焦虑症患者
- 批准号:
10705005 - 财政年份:2022
- 资助金额:
$ 4.55万 - 项目类别:
Developing an adjunctive mobile application for co-morbid substance use and anxiety disorders: comprehensive user experience testing of the Unwinding Anxiety application
开发针对共病药物使用和焦虑症的辅助移动应用程序:Unwinding Anxiety 应用程序的综合用户体验测试
- 批准号:
10597521 - 财政年份:2022
- 资助金额:
$ 4.55万 - 项目类别:
Investigating the role of neuroinflammation in environmental exposure-induced anxiety disorders
研究神经炎症在环境暴露诱发的焦虑症中的作用
- 批准号:
10573948 - 财政年份:2022
- 资助金额:
$ 4.55万 - 项目类别:














{{item.name}}会员




